Sign in

CIK 0001668243

  • Non-accelerated filer
  • Smaller reporting company

UroGen Pharma Ltd.

Sign in to watch
Ticker
URGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 97707601
Business address
9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
  1. 4 Exercise or conversion Chief Medical Officer acquired 13,333 shares (option exercise)
  2. 4 Derivatives Options or other derivatives
  3. 4 Exercise or conversion Director acquired 2,000 shares (option exercise)
  4. 4 Exercise or conversion Director acquired 2,000 shares (option exercise)
  5. 4 Exercise or conversion Director acquired 2,000 shares (option exercise)
  6. 4 Exercise or conversion Director acquired 2,000 shares (option exercise)
  7. 4 Exercise or conversion Director acquired 2,000 shares (option exercise)
  8. 4 Planned sale Chief Medical Officer sold 10,000 shares at $25.00 ($250,000)
  9. 4 Open-market sale Chief Financial Officer sold 2,203 shares at $16.85 ($37,121)
  10. 4 Open-market sale Chief Medical Officer sold 871 shares at $19.11 ($16,645)
  11. 4 Open-market sale General Counsel sold 1,520 shares at $19.11 ($29,047)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Open-market sale Chief Medical Officer sold 10,000 shares at $17.69 ($176,900)
  19. 4 Derivatives Options or other derivatives
  20. 4 Open-market sale General Counsel sold 7,522 shares at $19.14 ($143,971)

Page 2 of 12 · 233 filings